Compare RYAN & SHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RYAN | SHC |
|---|---|---|
| Founded | 2010 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Specialty Insurers | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.9B | 4.4B |
| IPO Year | 2021 | 2020 |
| Metric | RYAN | SHC |
|---|---|---|
| Price | $30.67 | $15.67 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 17 | 7 |
| Target Price | ★ $50.88 | $20.33 |
| AVG Volume (30 Days) | 1.9M | ★ 2.3M |
| Earning Date | 04-30-2026 | 05-05-2026 |
| Dividend Yield | ★ 1.48% | N/A |
| EPS Growth | N/A | ★ 68.75 |
| EPS | N/A | ★ 0.27 |
| Revenue | ★ $3,051,126,000.00 | $1,163,617,000.00 |
| Revenue This Year | $15.78 | $7.51 |
| Revenue Next Year | $12.49 | $6.00 |
| P/E Ratio | $86.72 | ★ $57.43 |
| Revenue Growth | ★ 21.28 | 5.74 |
| 52 Week Low | $31.50 | $10.80 |
| 52 Week High | $72.50 | $19.85 |
| Indicator | RYAN | SHC |
|---|---|---|
| Relative Strength Index (RSI) | 28.57 | 53.82 |
| Support Level | N/A | $15.18 |
| Resistance Level | $38.61 | $16.55 |
| Average True Range (ATR) | 1.35 | 0.40 |
| MACD | -0.31 | -0.02 |
| Stochastic Oscillator | 8.85 | 35.46 |
Ryan Specialty Holdings Inc is an international specialty insurance intermediary providing specialty products, solutions, and services for insurance brokers, agents, and carriers. The company offers wholesale insurance brokerage and delegated underwriting authority products and services, including distribution, underwriting, product development, administration, and risk management. Its expertise spans property, casualty, professional lines, transportation, personal lines, workers compensation, and employee benefits insurance, across traditional insurance and alternative risk solutions. The company operates in the United States and foreign markets, with the majority of revenue generated from the United States.
Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical, and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three reportable segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment, which generates maximum revenue, provides outsourced terminal sterilization and irradiation services for medical devices, pharmaceuticals, food safety, and other application markets using three core technologies: gamma irradiation, EO processing, and E-beam irradiation. Geographically, the company generates maximum revenue from the United States, followed by Canada, Europe, and other regions.